Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dichloroethane | decreases expression | ISO | Kcns2 (Mus musculus) | 6480464 | ethylene dichloride results in decreased expression of KCNS2 mRNA | CTD | PMID:28960355 | 17alpha-ethynylestradiol | increases expression | ISO | Kcns2 (Rattus norvegicus) | 6480464 | Ethinyl Estradiol results in increased expression of KCNS2 mRNA | CTD | PMID:29097150 | 2,2',5,5'-tetrachlorobiphenyl | decreases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:36804509 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Kcns2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of KCNS2 mRNA | CTD | PMID:21570461 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Kcns2 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of KCNS2 mRNA | CTD | PMID:32109520 | 3,4-methylenedioxymethamphetamine | increases expression | ISO | Kcns2 (Mus musculus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of KCNS2 mRNA | CTD | PMID:20188158 | 4,4'-diaminodiphenylmethane | increases expression | ISO | Kcns2 (Mus musculus) | 6480464 | 4 and 4'-diaminodiphenylmethane results in increased expression of KCNS2 mRNA | CTD | PMID:18648102 | 4,4'-sulfonyldiphenol | increases methylation | ISO | Kcns2 (Mus musculus) | 6480464 | bisphenol S results in increased methylation of KCNS2 exon and bisphenol S results in increased methylation of KCNS2 promoter | CTD | PMID:33297965 | all-trans-retinoic acid | multiple interactions | ISO | Kcns2 (Mus musculus) | 6480464 | [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of KCNS2 mRNA | CTD | PMID:36189433 | ammonium chloride | affects expression | ISO | Kcns2 (Rattus norvegicus) | 6480464 | Ammonium Chloride affects the expression of KCNS2 mRNA | CTD | PMID:16483693 | antirheumatic drug | increases expression | EXP | | 6480464 | Antirheumatic Agents results in increased expression of KCNS2 mRNA | CTD | PMID:24449571 | benzo[a]pyrene | increases methylation | EXP | | 6480464 | Benzo(a)pyrene results in increased methylation of KCNS2 3' UTR more ... | CTD | PMID:27901495 | bisphenol A | decreases expression | ISO | Kcns2 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of KCNS2 mRNA | CTD | PMID:25181051 | bisphenol A | decreases expression | ISO | Kcns2 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of KCNS2 mRNA | CTD | PMID:32156529 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of KCNS2 mRNA | CTD | PMID:27685785 | cisplatin | increases expression | EXP | | 6480464 | Cisplatin results in increased expression of KCNS2 mRNA | CTD | PMID:27392435 | copper atom | increases expression | ISO | Kcns2 (Rattus norvegicus) | 6480464 | Copper deficiency results in increased expression of KCNS2 mRNA | CTD | PMID:26033743 | copper atom | multiple interactions | ISO | Kcns2 (Rattus norvegicus) | 6480464 | [Copper co-treated with Dietary Sucrose] results in increased expression of KCNS2 mRNA | CTD | PMID:26033743 | copper(0) | multiple interactions | ISO | Kcns2 (Rattus norvegicus) | 6480464 | [Copper co-treated with Dietary Sucrose] results in increased expression of KCNS2 mRNA | CTD | PMID:26033743 | copper(0) | increases expression | ISO | Kcns2 (Rattus norvegicus) | 6480464 | Copper deficiency results in increased expression of KCNS2 mRNA | CTD | PMID:26033743 | dibutyl phthalate | decreases expression | ISO | Kcns2 (Mus musculus) | 6480464 | Dibutyl Phthalate results in decreased expression of KCNS2 mRNA | CTD | PMID:17361019 and PMID:21266533 | disodium selenite | decreases expression | EXP | | 6480464 | Sodium Selenite results in decreased expression of KCNS2 mRNA | CTD | PMID:18175754 | doxorubicin | increases expression | EXP | | 6480464 | Doxorubicin results in increased expression of KCNS2 mRNA | CTD | PMID:29803840 | ethanol | affects splicing | ISO | Kcns2 (Mus musculus) | 6480464 | Ethanol affects the splicing of KCNS2 mRNA | CTD | PMID:30319688 | ethanol | affects expression | ISO | Kcns2 (Mus musculus) | 6480464 | Ethanol affects the expression of KCNS2 mRNA | CTD | PMID:30319688 | lead(0) | affects expression | EXP | | 6480464 | Lead affects the expression of KCNS2 mRNA | CTD | PMID:28903495 | lipopolysaccharide | multiple interactions | EXP | | 6480464 | [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of KCNS2 mRNA | CTD | PMID:35811015 | lipopolysaccharide | increases expression | EXP | | 6480464 | Lipopolysaccharides results in increased expression of KCNS2 mRNA | CTD | PMID:35811015 | mono(2-ethylhexyl) phthalate | multiple interactions | ISO | Kcns2 (Mus musculus) | 6480464 | [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of KCNS2 mRNA | CTD | PMID:36189433 | potassium dichromate | increases expression | ISO | Kcns2 (Mus musculus) | 6480464 | Potassium Dichromate results in increased expression of KCNS2 mRNA | CTD | PMID:23608068 | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | EXP | | 6480464 | [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of KCNS2 mRNA | CTD | PMID:35811015 | sodium fluoride | decreases expression | ISO | Kcns2 (Mus musculus) | 6480464 | Sodium Fluoride results in decreased expression of KCNS2 mRNA | CTD | PMID:27862939 | valproic acid | increases methylation | EXP | | 6480464 | Valproic Acid results in increased methylation of KCNS2 gene | CTD | PMID:29154799 | |